Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2012
10/04/2012US20120252903 Cholesterol control agent
10/04/2012US20120252898 Method of producing a stabilized naturally occuring hydroxycitric acid (hca) from garcinia indica fruit
10/04/2012US20120252887 Composition and method for treating diabetes and metabolic disorders
10/04/2012US20120252884 Modified and Stabilized GDF Propeptides and Uses Thereof
10/04/2012US20120252872 RNAi Modulation of APOB and Uses Thereof
10/04/2012US20120252869 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
10/04/2012US20120252865 Carbamate derivatives in particular for the treatment of neurological disorders
10/04/2012US20120252862 Dissolvable Film Strip Comprising Natural Components
10/04/2012US20120252859 Tricyclic Indeno-Pyrrole Derivatives as Serotonin Receptor Modulators
10/04/2012US20120252854 Crystalline forms of thiazolidinedione compound and its manufacturing method
10/04/2012US20120252853 Positive allosteric modulators of nicotinic acetylcholine receptor
10/04/2012US20120252850 Niacin conjugated fatty acid mixtures and their uses
10/04/2012US20120252837 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
10/04/2012US20120252830 Substituted Aminobutyric Derivatives as Neprilysin Inhibitors
10/04/2012US20120252825 Beneficial effects of combination therapy on cholesterol
10/04/2012US20120252824 Drug Combinations and Uses in Treating a Coughing Condition
10/04/2012US20120252823 Adenosine receptor agonists, partial agonists, and antagonists
10/04/2012US20120252817 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
10/04/2012US20120252814 Glucokinase Activators
10/04/2012US20120252813 Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
10/04/2012US20120252812 6-pyrimidinyl-pyrimid-4-one derivative
10/04/2012US20120252810 Fatty acid non-flushing niacin derivatives and their uses
10/04/2012US20120252800 Bicyclic thiazoles as allosteric modulators of mglur5 receptors
10/04/2012US20120252799 Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/04/2012US20120252798 Indole compounds as an inhibitor of cellular necrosis
10/04/2012US20120252796 Compounds for the treatment of dyslipidemia and related diseases
10/04/2012US20120252795 Oral lysophilisates containing pvp/va
10/04/2012US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase
10/04/2012US20120252789 Inhibitors of sphingosine kinase
10/04/2012US20120252788 5ht2c receptor modulators
10/04/2012US20120252787 Administration of an anti-obesity compound to individuals with renal impairment
10/04/2012US20120252786 5ht2c receptor modulator compositions and methods of use
10/04/2012US20120252783 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
10/04/2012US20120252782 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
10/04/2012US20120252780 Bicyclic pyridines and analogs as sirtuin modulators
10/04/2012US20120252778 Pyrazolo pyrimidine derivatives
10/04/2012US20120252777 Thiazolopyrimidine compounds
10/04/2012US20120252759 Thiazole derivatives for the treatment of diseases such as cancer
10/04/2012US20120252754 Candy Cakes
10/04/2012US20120252740 Hdac inhibitors and therapeutic methods of using same
10/04/2012US20120252732 Albumin fusion proteins
10/04/2012US20120252724 Insulin preparations containing methionine
10/04/2012US20120252723 Regulating the Amino Acid Pool Used for the Acute-Phase Protein Synthesis
10/04/2012US20120252722 Metal-binding therapeutic peptides
10/04/2012US20120252097 Therapeutic Agents Comprising Pro-Apoptotic Proteins
10/04/2012US20120251643 Anti-diabetic extract of honeybush
10/04/2012US20120251638 Nutritional Supplement Comprising Nut Oil Composition
10/04/2012US20120251636 Compositions and Methods for Controlling Metabolic Syndrome Using Whole fruit-derived Cranberry Ingredient Profile Enriched in Stress Adapted Bioactives (SABs)
10/04/2012US20120251621 Nutritionally Enhanced Fraction From Rice Bran And Method of Lowering Insulin Resistance Using Same
10/04/2012US20120251616 Tocopherols, Tocotrienols, Other Chroman and Side Chain Derivatives and Uses Thereof
10/04/2012US20120251589 Devices and methods for weight control and weight loss
10/04/2012US20120251587 Diabetes treatment
10/04/2012US20120251550 Crystalline anti-hTNFalpha antibodies
10/04/2012US20120251547 Il-17 receptor a antigen binding proteins
10/04/2012US20120251539 Methods and Compositions for the Treatment of Immune Disorders
10/04/2012US20120251533 Monoclonal antibodies against cd30 lacking in fucosyl residues
10/04/2012US20120251527 Podocyte specific assays and uses thereof
10/04/2012US20120251525 Method of utilizing azelaic acid esters to modulate communications mediated by biological molecules
10/04/2012US20120251507 Compositions for preventing cardiac arrhythmia
10/04/2012US20120251495 Pterin based therapies for inflammatory conditions
10/04/2012US20120251486 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
10/04/2012US20120251457 Methods and compositions for modulating adipocyte function
10/04/2012CA2831771A1 Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases
10/04/2012CA2831716A1 Compounds for treatment of metabolic syndrome
10/04/2012CA2831554A1 Agent for improving or maintaining qol
10/04/2012CA2831190A1 Trpm5 inhibitors support body weight reduction without reducing food intake
10/04/2012CA2831184A1 Method for encapsulated therapeutic products and uses thereof
10/04/2012CA2830811A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients
10/04/2012CA2830664A1 Pegylated human hdl particle and process for production thereof
10/04/2012CA2830447A1 New azaspirodecanone compounds as hsl inhibitors
10/04/2012CA2830375A1 Methods and compositions for targeting adipose cells in mammals
10/04/2012CA2829241A1 Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
10/04/2012CA2829122A1 Site-directed mono-substituted pegylated exendin analog and preparation method therefor
10/03/2012EP2505660A1 Method for screening of therapeutic agent for hyperlipemia
10/03/2012EP2505639A1 Method for manufacturing pancreatic-hormone-producing cells
10/03/2012EP2505587A1 Method for manufacturing a 6-substituted-1-methyl-1h-benzimidazole derivative, and manufacturing intermediate from said method
10/03/2012EP2505201A1 Trmp5 inhibitors support body weight reduction without reducing food intake
10/03/2012EP2504035A2 Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites
10/03/2012EP2504026A1 Composition comprising a combination of at least one proteolytic enzyme and at least one lipolytic enzyme, for use in preventing triglyceride synthesis
10/03/2012EP2504021A1 Polypeptide conjugate
10/03/2012EP2504018A1 Antidiabetic composition comprising a plant extract of englerina lecardii
10/03/2012EP2504010A1 Fused bicyclic pyrimidine derivatives and methods of use thereof
10/03/2012CN1993463B Follistatin mutant polypeptide
10/03/2012CN102712626A Piperazine compound having a PGDS inhibitory effect
10/03/2012CN102712620A 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds
10/03/2012CN102712610A Novel 3-hydroxy-5-arylisothiazole derivative
10/03/2012CN102711832A Composition for controlling weight gain and food product containing same
10/03/2012CN102711805A Pharmaceutical composition comprising a GLP-1 agonist, an insulin, and methionine
10/03/2012CN102711804A Pharmaceutical composition comprising a GLP-1 agonist and methionine
10/03/2012CN102711800A Composition and method for treatment of diabetes
10/03/2012CN102711789A Therapeutic agents for reducing parathyroid hormone levels
10/03/2012CN102711781A A novel boswellia low polar gum resin extract and its synergistic compositions
10/03/2012CN102711774A Composition for preventing and treating obesity diseases containing highly water-soluble 2-hydroxypropyl-[beta]-cyclodextrin as active ingredient
10/03/2012CN102711763A Pharmaceutical composition for oral administration
10/03/2012CN102711762A Solid pharmaceutical composition for oral administration
10/03/2012CN102711761A Elution-stabilized preparation
10/03/2012CN102703296A Lycium ruthenicum health-care wine
10/03/2012CN102702582A Zeamays L. polysaccharide and preparation method and application thereof
10/03/2012CN102702355A Anti FGF23 antibody and a pharmaceutical composition comprising the same
10/03/2012CN102702330A Intermedin analogue prepared by bonding ring core sequence with biotin or cell-penetrating peptides
1 ... 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 ... 1298